Answer
Reported changes with selumetinib include skin rash (including maculopapular and acneiform rash), dry skin, paronychia and hair changes, including hair colour changes.
Sources for this answer
- Koselugo 5 mg granules in capsule for openingAstraZeneca UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked